Journal of Ophthalmic and Vision Research

: 2015  |  Volume : 10  |  Issue : 3  |  Page : 250--256

Outcomes of cataract surgery at a referral center

Seyed-Farzad Mohammadi1, Hassan Hashemi2, Arash Mazouri1, Nazanin Rahman-A1, Elham Ashrafi3, Hadi Z Mehrjardi1, Ramak Roohipour1, Akbar Fotouhi4,  
1 Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran
2 Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences; Department of Ophthalmology, Noor Ophthalmology Research Center, Noor Eye Hospital, Tehran, Iran
3 Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences; Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
4 Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Correspondence Address:
Elham Ashrafi
Farabi Eye Hospital, Qazvin Square, Tehran 13366


Purpose: To report the outcomes of cataract surgery at a large referral eye hospital and to identify factors associated with less than excellent visual outcomes. Methods: Hospital records of patients, who had undergone age-related cataract extraction (1,285 procedures) within a two-year period were sampled randomly for 353 patients (405 eyes) and baseline characteristics were recorded. Up to three causes of visual loss (contributory reasons) were considered and the principal cause of "less than excellent outcome," i.e., best spectacle corrected visual acuity (BSCVA) <20 /25 was defined as the primary reason. Results: Mean age of the participants was 68.6 years, and 50.7% of enrolled subjects were female. Phacoemulsification had been performed in 92.1% of cases. Out of 405 eyes, 54%, 78%, and 97% achieved BSCVA of <20/25, <20/40, and <20/200, respectively. Poor visual outcomes were significantly associated with older age (OR: 4.55 for age >70 years), female gender (OR: 4.64), ocular comorbidities (OR: 7.68), surgically challenging eyes (OR: 7.33), long and short eyes (versus eyes with normal axial length, OR: 3.24), and being operated on by a novice surgeon (OR: 2.41). The leading contributory reasons for unfavorable outcome, in descending order were maculopathy (17%), posterior capsule opacification (PCO, 11.8%), corneal opacity (5.7%), and degenerative myopia (5.4%). Conclusion: Maculopathy, PCO, corneal opacity, degenerative myopia and ARMD may contribute to unfavorable outcomes in cataract surgery.

How to cite this article:
Mohammadi SF, Hashemi H, Mazouri A, Rahman-A N, Ashrafi E, Mehrjardi HZ, Roohipour R, Fotouhi A. Outcomes of cataract surgery at a referral center.J Ophthalmic Vis Res 2015;10:250-256

How to cite this URL:
Mohammadi SF, Hashemi H, Mazouri A, Rahman-A N, Ashrafi E, Mehrjardi HZ, Roohipour R, Fotouhi A. Outcomes of cataract surgery at a referral center. J Ophthalmic Vis Res [serial online] 2015 [cited 2020 Jan 23 ];10:250-256
Available from:

Full Text


Cataract is the leading cause of treatable blindness worldwide and 75% of people with cataracts live in developing countries where blindness is associated with considerable disability, and major economic and social consequences.[1],[2],[3] Recent population-based reports from several developing countries show that 21-50% of people who have had cataract surgery have presenting visual acuity (VA) <6 /18 in the operated eye, and 11-23% have <6/60 VA.[4],[5],[6],[7],[8],[9],[10],[11]

It has been suggested that surgical outcome in developing countries is noticeably poorer than those of developed countries.[12],[13] Studies have pointed to factors, including patient selection and visual potential, cataract surgery technique and intraoperative events, and postoperative care as contributors to the outcome.[14],[15]

Herein, we report the outcomes of cataract surgery at a university based eye hospital in the capital of Iran, Tehran. The factors and reasons for a 'less than excellent' outcome in that setting were analyzed.



The study was conducted at Farabi Eye Hospital, a university-affiliated hospital, and the largest eye referral center in Northern Iran; the study protocol was approved by the Institute Review Board. This hospital has an annual volume of about 33,000 surgical procedures of which >13,000 are cataract procedures. Corresponding annual patient visits are >300,000.

Out of 6,701 patients aged over 50 years who underwent cataract surgery within a two-year period (2006-2007), 1,285 records were randomly selected and baseline characteristics were documented. Patients were recruited for an outcome visit from this pool, and when the intended sample reached >350 patients (400 eyes), sampling was terminated. Participants from the randomly selected pool were assessed for the study. Further aspects of sampling and participant flow have been reported elsewhere.[16]

Baseline data and surgical details, including biometry were extracted from the records, alongside preoperative and surgical examination sheets. A current medical history was taken and an ophthalmic examination, including refraction, slit lamp biomicroscopy, Goldmann applanation tonometry and posterior segment examination, was comprehensively updated. Ocular comorbidities and sequelae of surgical complications were sought in the records and during the outcome visit. Participants were provided with refraction, suture removal and YAG laser capsulotomy (in case of visually significant posterior capsule opacification, PCO). Further advice was given and prudent follow-up was planned for ocular comorbidities.

Five qualitative categories were considered for visual acuity (VA): Excellent (<20/25); satisfactory (20/40 to <20/25); acceptable (20/100 to <20/40); borderline (20/200 to <20/100); and poor (≤20/200). The cut-offs were reached based on literature review,[17] and expert opinion. A standardized scheme was used to explain any visual loss. Best spectacle-corrected VA (BSCVA) <20 /25 was defined as "less than excellent outcome". During the study, up to three causes of visual loss were listed in descending order regarding their perceived role in visual loss. The principal cause of less than excellent outcome was defined as the primary reason.

Axial length was categorized as short (<22 mm), normal (22-24.5 mm), and long (>24.5 mm). Ocular comorbidities were subcategorized into "surgically challenging eyes" (including pseudoexfoliation syndrome (PXF), phacodonesis, miotic pupil and corneal opacity) and eyes with "guarded visual potential" (including age-related macular degeneration [ARMD], glaucoma, vision-threatening diabetic retinopathy, corneal opacity, and degenerative myopia). A "novice surgeon" category defined junior residents.

Statistical Analysis

Despite the conversion of VA data into logMAR notations, BSCVA data did demonstrate normal distribution (Kolmogorov-Smirnov test, P < 0.001), and non-parametric tests were used. The Mann-Whitney U-test was used to assess associations between BSCVA and sex, systemic comorbidities, ocular comorbidities, cataract maturity, surgeon competence, surgical approach (temporal, or superior), incision type (corneal, or scleral), anesthesia, and surgery timing. The Kruskal-Wallis test was used to assess relationships between BSCVA and age groups, axial length categories and surgical technique.


The participation rate for the study was 51%. Baseline and surgical characteristics of responsive and non-responsive subjects were compared which revealed that the participants were actually representative of the randomly selected pool in terms of the study variables. These included female gender (participants vs. non-participants: 49.9% vs. 53.6%), phacoemulsification rate (92.8% vs. 90%), mean age at surgery (68.6 vs. 69.3 years), mature cataract rate (13.6% vs. 14.7%), intraocular lens power (19.70 D vs. 19.74 D), vitreous loss rate (1.7% vs. 2%), and aphakia rate (0.5% vs. 1%), respectively.

Of 353 cataract operated participants (405 eyes), 179 patients (50.7%) were female (203 eyes). Mean age at surgery was 68.6 ± 9.2 years. The cataract extraction technique included phacoemulsification (92.1%), small incision cataract surgery (SICS, 3.7%) and extracapsular cataract extraction (ECCE, 4.2%). More than half of the eyes (53.8%) had an excellent outcome (BSCVA <20/25) and close to 80% had a BSCVA of 20/40 or better. Only 2.8% of the eyes (n = 11) had BSCVA <20/200. Mean values for BSCVA and uncorrected visual acuity (UCVA) following cataract surgeries were 0.22 and 0.35 logMAR, respectively.

Postoperative BSCVA Determinants

Age, gender, and systemic conditions

Visual outcome and age were inversely correlated; mean age at the time of surgery was 71.6 years in cases with a poor visual outcome vs. 66.3 years in subjects with an excellent outcome (P < 0.001). Male patients achieved better BSCVA than female counterparts (median: 0.07 vs. 0.15 logMAR, P < 0.001). 'Excellent' vision was achieved in 63.1% of male cases vs. 44.7% of female subjects (P < 0.001). Systemic conditions, including hypertension, hyperlipidemia, ischemic heart disease and diabetes mellitus were present in 220 (54.3%) of eyes, but none of these conditions were significantly association with BSCVA (P = 0.65) [Table 1].{Table 1}

Ocular comorbidities, axial length, and mature cataract

Out of 405 eyes, 119 (29.4%) had ocular comorbidities including ARMD (n = 35, 8.6%), vision-threatening diabetic retinopathy (n = 11, 2.7%), glaucoma (n = 21, 5.2%), corneal opacity (n = 31, 7.7%) and degenerative myopia (n = 21, 5.2%). Eyes with guarded visual potential had lower median BSCVA than others (0.35 vs. 0.05 logMAR, P < 0.001). Surgically challenging eyes similarly had lower median BSCVA (0.2 vs. 0.07 logMAR, P = 0.002). An excellent outcome (BSCVA < 20/25) was achieved in 37.9%, and 12.9% of surgically challenging eyes and those with guarded visual potential, respectively.

An excellent outcome was achieved in 65% of eyes with none of these problems (P < 0.001). Median BSVCA for long, short and normal-sized eyes were: 0.3, 0.43 and 0.07 logMAR, respectively (P < 0.001). There was no significant association between cataract maturity and BSCVA (P = 0.49).

Surgeon competence and surgical routines

Close to 66% (269) of eyes were operated by highly skilled surgeons. Being operated by a novice, rather than an experienced cataract surgeon, was associated with worse visual outcome (median BSCVA 0.15 vs. 0.08 logMAR, P = 0.01), and more vitreous loss (3.64 vs. 1.43%, P = 0.01). There were no significant relationship between treatment modalities, surgical approach (temporal vs. superior), type of anesthesia, or surgery timing and BSCVA. However, eyes with corneal incisions had better BSCVA (0.07 vs. 0.19 median logMAR, P = 0.004) [Table 1].

Contributing and Primary Causes of Postoperative BSCVA <20/25

Contributory reasons for less than excellent outcomes were maculopathy (17%, n = 68), PCO (11.8%), corneal opacity (5.7%) and degenerative myopia (5.4%) [Table 2]. The three most common primary causes of less than excellent outcome are listed in [Table 3]. Corneal opacity, dry ARMD, PCO and maculopathy were the most common conditions causing poor, borderline, acceptable and satisfactory BSCVA, respectively.{Table 2}{Table 3}

Postoperative UCVA

Out of 405 operated eyes, 31% (122 eyes) had UCVA >20/25. Only 5.6% of eyes (n = 22) had UCVA <20/200. Satisfactory (<20/40 to <20/25), acceptable (<20/100 to <20/40) and borderline (<20/200 to <20/100) UCVA outcomes were achieved in 31.7% (n = 125), 25.1% (n = 99), and 6.6% (n = 26) of eyes, respectively. UCVA data and refractive aspects were analyzed and have been reported elsewhere.[16] Subjective satisfaction was close to 80% in the participants.

Postoperative complications

Seventy-two eyes (17.7%) developed complications. Seven eyes (1.7%) had posterior capsule rupture (95% CI, 1.6-1.8%), and eight eyes (2%) had retained sutures. Bullous keratopathy was found in one eye, and one patient was operated for pseudophakic retinal detachment. A visually significant PCO was found in 13.1%, including eyes that had already undergone capsulotomy.


In the current series, more than 78% of operated eyes had postoperative BSCVA of 20/40, or better, and only 2.8% had BSCVA worse than 20/200. Although the current study is a hospital-based study, the results are comparable to previously reported postoperative visual acuities from large studies in the United States, Canada, Denmark, Spain, United Kingdom and Sweden,[18],[19],[20],[21],[22] and remarkably better, with lower complication rates than those in developing countries.[12] This difference may be attributed to our hospital-based setting and the fact that most procedures (>90%) employed phacoemulsification, analogous to developed countries, which is known to be associated with better outcomes. There has been a well-established transition into phacoemulsification in Iran [23] but SICS and ECCE are still the preferred methods of cataract surgery in many developing countries,[24] owing to cost and a technological gap. Despite the university affiliation of our hospital, most eyes (66.4%) were treated in the non-educational service by experienced phacoemulsification surgeons, and operations in the educational setting were supervised by the faculty.

BSCVA of 6/18 (equivalent to 20/60), or better has been recommended by the World Health Organization (WHO), as indicative of good visual outcome following cataract surgery,[17] but advances in cataract surgery, and parallel changes in patient expectations warrant setting higher cut-offs; for instance, in this study BSCVA <20/40 was achieved in about 80% of operated eyes, while over half of the eyes achieved <20/25. We believe that UCVA <20/40 and BSCVA <20/25 provide better cut off values for studying the outcome of cataract surgery in future studies.

Older age and a female gender have been associated with less satisfactory visual outcomes following cataract surgery,[25],[26],[27] as also observed in this study. This issue has addressed elsewhere in a comprehensive manner.[28]

Eyes with ocular comorbidities (PXF, corneal opacity, glaucoma, visually significant diabetic retinopathy, ARMD, and degenerative myopia) which were denoted as "surgically challenging eyes," or eyes with "guarded visual potential" had significantly poorer BSCVA which is consistent with previous reports.[10],[15],[17] Forooghianet al showed that eyes without ARMD gained 8.4 letters of acuity, but eyes with advanced ARMD gained 1.9 letters. This implies that even patients with ARMD may benefit from cataract surgery.[29],[30] Cataract surgery in PXF is known to be associated with more complications.[30],[31] In this study, eyes with PXF had poorer outcome; this could be due to a glaucomatous status, or anterior segment features that made the surgery challenging. However, some studies suggest that with suitable preoperative preparation, intraoperative use of appropriate devices, and suitable follow-up, good outcomes can also be achieved in eyes with PXF.[32]

The influence of axial length has been reported in previous studies.[33] In our series, eyes with axial length <22 mm, or >24.5 mm had substantially less satisfactory outcomes [Table 1]. High axial length correlates with degenerative myopia which reduces visual potential. The poorer outcome in short-eyes may be explained by the high frequency of amblyopia in such eyes.

The effect of surgeon competence, specifically regarding phacoemulsification has already been reported,[30],[34] and was replicated in this study [Table 1]. The difference might have been underestimated, as more challenging cases (with guarded status) were more frequently operated by experienced surgeons. There is an opportunity to improve outcomes through better supervision, and transfer of skills in phacoemulsification. This challenge is specifically relevant to developing countries still in transition to phacoemulsification.

Due to the small size of ECCE and SICS subgroups, their outcomes could not be compared with phacoemulsification. Although, incision site had a significant association with BSCVA, this finding is likely a coincidence rather than a cause.

Except diabetes mellitus (accompanied by vision-threatening diabetic retinopathy), systemic comorbidities were not associated with poor visual outcomes and hence cataract patients with systemic problems can benefit equally from cataract surgery. Cataract maturity also did not adversely affect postoperative BSCVA.

This study substantiates the importance of patient selection in cataract surgery.[22],[35]

Based on the observations of this study and regarding advances in cataract surgery, a change is recommended from "patient selection" to the concept of "patient counseling and surgical planning". Therefore, vision improvement alongside with patient expectations should be addressed. Also a suitable level of resources should be provided to handle the eyes with a surgically challenging status.

Twelve distinct reasons were listed in [Table 2] for visual loss in these patients. The five leading contributory factors for less than excellent outcome in descending order were: Maculopathy, PCO, corneal opacity, degenerative myopia and ARMD. PCO and corneal opacity have consistently been reported as causes of visual loss in cataract-extracted eyes.[36],[37] PCO is recognized as the most common complication of cataract surgery; untreated PCO existed in about 12% of operated eyes. It is believed that patients should be informed about this long-term complication and encouraged to seek follow-up care. PCO in the data set has been extensively described elsewhere.[38],[39] Corneal opacity is a common finding in senior citizens of developing countries.[40] In the current series is was listed among the top three primary reasons for poor visual outcome [Table 3]. Corneal opacity is frequently a result of cicatricial trachoma. But, other infectious causes, like childhood viral infections and interstitial keratitis, along with vitamin-A deficiency may contribute to the condition.

Choosing a BSCVA cut off value of >20/25 caused emergence of maculopathy, as the major cause of impaired vision in the range of 20/40 to 20/25 [Table 3], and other categories of impaired vision in general [Table 2]. Maculopathy covers distinct diagnoses such as macular hole and epiretinal membrane, and non-specific pigmentary changes which were common because of resolved cystoid macular edema, old trauma (resolved Berlin's edema), resolved central serous chorioretinopathy, eclipse retinopathy, old retinal detachment, etc.

The major cause of visual loss in cataract extracted eyes varied according to the degree of visual loss;[41] the following approximate inferences could be made: Mild maculopathy and PCO cause mild visual loss; corneal opacity causes moderate visual loss; and degenerative myopia, dysplastic disc and ARMD cause severe visual loss [Table 3].

Our observations should be generalized cautiously, as many patients in the selected sample were not reachable, deceased, or noncompliant, and also because the setting was hospital-based. However, since the study center is a major public referral hospital, a wide spectrum of simple to complicated cataract surgery candidates was represented. The educational setting and the surgeon mix add a new dimension, i.e., competence variation, which further expands the scope of the study.

In summary, our results suggest that with suitable knowledge transfer and skill acquisition, the outcomes of cataract surgery, including phacoemulsification, could be as desirable as that in developed nations. Surgically challenging eyes and eyes with guarded visual potential (e.g., pseudoexfoliation syndrome or corneal opacity), and eyes operated on by novice surgeons had poorer outcomes. In this study, the five leading factors contributing to less than excellent outcome, in descending order, were maculopathy, PCO, corneal opacity, degenerative myopia and ARMD, which cause mild, moderate, and severe visual loss, respectively.

Financial Support and Sponsorship

The study was partially supported by a grant from the Ministry of Health (#7491) awarded to the Eye Research Center of Tehran University of Medical Sciences for achieving an honor degree in Razi Medical Sciences Research Festival at 2006.

Conflicts of Interest

There are no conflicts of interest.


1What is Vision 2020? Available from: [Last accessed on 2012 Aug].
2Pizzarello L, Abiose A, Ffytche T, Duerksen R, Thulasiraj R, Taylor H, et al. VISION 2020: The right to sight: A global initiative to eliminate avoidable blindness. Arch Ophthalmol 2004;122:615-620.
3Frick KD, Foster A. The magnitude and cost of global blindness: An increasing problem that can be alleviated. Am J Ophthalmol 2003;135:471-476.
4Eusebio C, Kuper H, Polack S, Enconado J, Tongson N, Dionio D, et al. Rapid assessment of avoidable blindness in Negros Island and Antique District, Philippines. Br J Ophthalmol 2007;91:1588-1592.
5Nkomazana O. A national survey of visual impairment in Botswana. Community Eye Health 2007;20:9.
6Katibeh M, Ziaei H, Rajavi Z, Hosseini S, Javadi MA. Profile of cataract surgery in Varamin Iran: A population-based study. Clin Experiment Ophthalmol 2014;42:354-359.
7Habiyakire C, Kabona G, Courtright P, Lewallen S. Rapid assessment of avoidable blindness and cataract surgical services in Kilimanjaro region, Tanzania. Ophthalmic Epidemiol 2010;17:90-94.
8Mathenge W, Kuper H, Limburg H, Polack S, Onyango O, Nyaga G, et al. Rapid assessment of avoidable blindness in Nakuru district, Kenya. Ophthalmology 2007;114:599-605.
9Mathenge W, Nkurikiye J, Limburg H, Kuper H. Rapid assessment of avoidable blindness in Western Rwanda: Blindness in a postconflict setting. PLoS Med 2007;4:e217.
10Bourne R, Dineen B, Jadoon Z, Lee PS, Khan A, Johnson GJ, et al. Outcomes of cataract surgery in Pakistan: Results from the Pakistan National Blindness and Visual Impairment Survey. Br J Ophthalmol 2007;91:420-426.
11Khanna RC, Pallerla SR, Eeda SS, Gudapati BK, Cassard SD, Rani PK, et al. Population based outcomes of cataract surgery in three tribal areas of Andhra Pradesh, India: Risk factors for poor outcomes. PLoS One 2012;7:e35701.
12Tabin G, Chen M, Espandar L. Cataract surgery for the developing world. Curr Opin Ophthalmol 2008;19:55-59.
13Ashwin PT, Shah S, Wolffsohn JS. Advances in cataract surgery. Clin Exp Optom 2009;92:333-342.
14Malik AR, Qazi ZA, Gilbert C. Visual outcome after high volume cataract surgery in Pakistan. Br J Ophthalmol 2003;87:937-940.
15Bourne RR, Dineen BP, Ali SM, Huq DM, Johnson GJ. Outcomes of cataract surgery in Bangladesh: Results from a population based nationwide survey. Br J Ophthalmol 2003;87:813-819.
16Hashemi H, Mehrjardi HZ, Majdi M, Mohammadi SF, Jabbarvand M, Mazouri A, et al. Cataract surgery outcome in a referral center: Farabi eye hospital, Tehran; study protocol. Iran J Ophthalmol 2012;24:17-25.
17World Health Organization. Informal consultation on analysis of blindness prevention outcomes. Geneva: WHO; 1998.
18Norregaard JC, Bernth-Petersen P, Alonso J, Andersen TF, Anderson GF. Visual functional outcomes of cataract surgery in the United States, Canada, Denmark, and Spain: Report of the international cataract surgery outcomes study. J Cataract Refract Surg 2003;29:2135-2142.
19Lundström M, Stenevi U, Thorburn W, Roos P. Catquest questionnaire for use in cataract surgery care: Assessment of surgical outcomes. J Cataract Refract Surg 1998;24:968-974.
20Powe NR, Schein OD, Gieser SC, Tielsch JM, Luthra R, Javitt J, et al. Synthesis of the literature on visual acuity and complications following cataract extraction with intraocular lens implantation. Cataract Patient Outcome Research Team. Arch Ophthalmol 1994;112:239-252.
21Zaidi FH, Corbett MC, Burton BJ, Bloom PA. Raising the benchmark for the 21st century – The 1000 cataract operations audit and survey: Outcomes, consultant-supervised training and sourcing NHS choice. Br J Ophthalmol 2007;91:731-736.
22Mönestam EI, Lundqvist B. Extended long-term outcomes of cataract surgery. Acta Ophthalmol 2012;90:651-656.
23Hashemi H, Mohammadi SF, Mazouri A, Majdi NM, Jabbarvand M, Mehrjardi HZ. Transition to phacoemulsification at the Farabi eye hospital, Iran. Middle East Afr J Ophthalmol 2011;18:173-177.
24Naeem M, Khan A, Khan MZ, Adil M, Abbas SH, Khan MU, et al. Cataract: Trends in surgical procedures and visual outcomes; a study in a tertiary care hospital. J Pak Med Assoc 2012;62:209-212.
25McKee M, Whatling JM, Wilson JL, Vallance-Owen A. Comparing outcomes of cataract surgery: Challenges and opportunities. J Public Health (Oxf) 2005;27:348-352.
26Lundström M, Stenevi U, Thorburn W. Cataract surgery in the very elderly. J Cataract Refract Surg 2000;26:408-414.
27Baruwa E, Tzu J, Congdon N, He M, Frick KD. Reversal in gender valuations of cataract surgery after the implementation of free screening and low-priced high-quality surgery in a rural population of southern China. Ophthalmic Epidemiol 2008;15:99-104.
28Hashemi H, Mohammadi SF, Mehrjardi HZ, Majdi M, Ashrafi E, Mehravaran S, et al. The role of demographic characteristics in the outcomes of cataract surgery and gender roles in the uptake of postoperative eye care: A hospital-based study. Ophthalmic Epidemiol 2012;19:242-248.
29Forooghian F, Agrón E, Clemons TE, Ferris FL 3rd, Chew EY; Age-Related Eye Disease Study Research Group. Visual acuity outcomes after cataract surgery in patients with age-related macular degeneration: Age-related eye disease study report no 27. Ophthalmology 2009;116:2093-2100.
30Armbrecht AM, Findlay C, Aspinall PA, Hill AR, Dhillon B. Cataract surgery in patients with age-related macular degeneration: One-year outcomes. J Cataract Refract Surg 2003;29:686-693.
31Shingleton BJ, Crandall AS, Ahmed II. Pseudoexfoliation and the cataract surgeon: Preoperative, intraoperative, and postoperative issues related to intraocular pressure, cataract, and intraocular lenses. J Cataract Refract Surg 2009;35:1101-1120.
32Belovay GW, Varma DK, Ahmed II. Cataract surgery in pseudoexfoliation syndrome. Curr Opin Ophthalmol 2010;21:25-34.
33de Juan V, Martín R, Pérez I, Herreras JM. Influence of axial length in refractive outcome after cataract surgery. Arch Soc Esp Oftalmol 2010;85:144-148.
34Randleman JB, Wolfe JD, Woodward M, Lynn MJ, Cherwek DH, Srivastava SK. The resident surgeon phacoemulsification learning curve. Arch Ophthalmol 2007;125:1215-1219.
35Chang MA, Congdon NG, Baker SK, Bloem MW, Savage H, Sommer A. The surgical management of cataract: Barriers, best practices and outcomes. Int Ophthalmol 2008;28:247-260.
36Zhao J, Ellwein LB, Cui H, Ge J, Guan H, Lv J, et al. Prevalence and outcomes of cataract surgery in rural China the China nine-province survey. Ophthalmology 2010;117:2120-2128.
37Huang W, Huang G, Wang D, Yin Q, Foster PJ, He M. Outcomes of cataract surgery in urban southern China: The Liwan eye study. Invest Ophthalmol Vis Sci 2011;52:16-20.
38Mohammadi SF, Sabbaghi M, Mehrjardi HZ, Hashemi H, Alizadeh S, Majdi M, et al. Using artificial intelligence to predict the risk for posterior capsule opacification after phacoemulsification. J Cataract Refract Surg 2012;38:403-408.
39Hashemi H, Mohammadi SF, Majdi M, Fotouhi A, Khabazkhoob M. Posterior capsule opacification after cataract surgery and its determinants. Iran J Ophthalmol 2012;24:3-8.
40Mpyet C, Solomon AW. Prevalence and causes of blindness and low vision in leprosy villages of north eastern Nigeria. Br J Ophthalmol 2005;89:417-419.
41Nirmalan PK, Thulasiraj RD, Maneksha V, Rahmathullah R, Ramakrishnan R, Padmavathi A, et al. A population based eye survey of older adults in Tirunelveli district of south India: Blindness, cataract surgery, and visual outcomes. Br J Ophthalmol 2002;86:505-512.